miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Report

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2017.5360PMID 28075453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer.

  2015cited by this paper
• Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.

  2015cited by this paper
• MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.

  2015cited by this paper
• MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.

  2014cited by this paper
• HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.

  2013cited by this paper
• Tamoxifen‐resistant breast cancer cells possess cancer stem‐like cell properties

  2013cited by this paper
• Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer

  2013cited by this paper
• MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells

  2012cited by this paper
• The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis.

  2011cited by this paper
• Cancer stem cells: Invitation to a second round

  2010cited by this paper
• The therapeutic promise of the cancer stem cell concept.

  2010cited by this paper
• The Hox genes and their roles in oncogenesis

  2010cited by this paper
• Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

  2010cited by this paper
• Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

  2009cited by this paper
• Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Cancer stem cells: mirage or reality?

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells

  2009cited by this paper
• Involvement of Pin1 induction in epithelial–mesenchymal transition of tamoxifen‐resistant breast cancer cells

  2009cited by this paper
• Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• The impact of microRNAs on protein output

  2008cited by this paper
• Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

  2008cited by this paper
• Cancer stem cell: target for anti‐cancer therapy

  2007cited by this paper
• HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.

  2006cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Self-assembly of mesoscopically ordered chromatic polydiacetylene/silica nanocomposites

  2001cited by this paper
• Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

  2000cited by this paper
• The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

  2000cited by this paper
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

  1993cited by this paper

• Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies

  2025cites this paper
• Near-infrared long lifetime upconversion nanoparticles for ultrasensitive microRNA detection via time-gated luminescence resonance energy transfer

  2025influential citation
• miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients

  2025cites this paper
• The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential.

  2024cites this paper
• Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions.

  2024cites this paper
• Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis

  2024cites this paper
• STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression

  2024cites this paper
• miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer

  2024cites this paper
• Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer

  2023cites this paper
• Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs.

  2023cites this paper
• Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment

  2023cites this paper
• EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.

  2022cites this paper
• RNA interference: Promising approach for breast cancer diagnosis and treatment

  2022cites this paper
• Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review

  2022cites this paper
• The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy

  2022cites this paper
• Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway

  2022influential citation
• CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR‐375/SLC7A11 axis

  2022cites this paper
• Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis

  2022cites this paper
• Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.

  2022cites this paper
• The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs.

  2022cites this paper
• Contribution of miRNAs in the Pathogenesis of Breast Cancer

  2021influential citation
• MicroRNAs as a clue to overcome breast cancer treatment resistance

  2021cites this paper
• MicroRNA-375: potential cancer suppressor and therapeutic drug

  2021cites this paper
• The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer

  2021cites this paper
• Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer

  2021cites this paper
• Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

  2021cites this paper
• Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells

  2021cites this paper
• LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p/STK4 pathway in prostate cancer

  2021cites this paper
• Signaling pathways governing breast cancer stem cells behavior

  2021cites this paper
• MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer

  2021cites this paper
• lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR-375 sponging

  2020cites this paper
• Prevention of breast cancer by dietary polyphenols—role of cancer stem cells

  2020cites this paper
• Chemotherapeutic Stress Influences Epithelial–Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer

  2020cites this paper
• Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.

  2020cites this paper
• HOX genes function in Breast Cancer development.

  2020cites this paper
• Screening key lncRNAs and mRNAs for left-sided and right-sided colon adenocarcinoma based on lncRNA-mRNA functional synergistic network

  2020cites this paper
• Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review

  2020cites this paper
• Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.

  2020cites this paper
• Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway

  2020cites this paper
• MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.

  2020cites this paper
• miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers

  2020cites this paper
• Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer

  2020cites this paper
• Liquiritin represses  proliferation , migration and invasion  of colorectal cancer cells through inhibition of the miR-671/HOXB3 signaling pathway

  2020cites this paper
• Network-based bioinformatics analysis of HOX genes and their related genes in endometriosis

  2020cites this paper
• Loss of HOXB3 promotes development of hormone receptor negative breast cancer

  2020cites this paper
• OTT_A_253468 5939..5953

  2020cites this paper
• The involvement of miR-375 in the adriamycin resistance of pancreatic carcinoma cells

  2019cites this paper
• MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.

  2019cites this paper
• Plasma extracellular vesicle-packaged microRNAs as candidate diagnostic biomarkers for early-stage breast cancer

  2019cites this paper
• Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers.

  2019cites this paper
• Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies

  2019cites this paper
• A Case of Identity: HOX Genes in Normal and Cancer Stem Cells

  2019cites this paper
• MicroRNA‐375‐3p inhibitor suppresses angiotensin II‐induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression

  2019cites this paper
• miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer

  2019cites this paper
• The Network of Non-coding RNAs in Cancer Drug Resistance

  2018cites this paper
• Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges

  2018cites this paper
• A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia

  2018cites this paper
• Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer

  2018cites this paper
• Role of HOX Genes in Stem Cell Differentiation and Cancer

  2018cites this paper
• miR‐191/DAB2 axis regulates the tumorigenicity of estrogen receptor‐positive breast cancer

  2018cites this paper
• Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

  2018cites this paper
• Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.

  2018cites this paper
• MicroRNA regulatory networks reflective of polyhexamethylene guanidine phosphate-induced fibrosis in A549 human alveolar adenocarcinoma cells.

  2018cites this paper
• MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma

  2017cites this paper
• Jefferson Digital

  year unknowncites this paper